Literature DB >> 20089698

Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity.

Gernot Sellge1, Joao G Magalhaes, Christoph Konradt, Jörg H Fritz, Wilmara Salgado-Pabon, Gérard Eberl, Antonio Bandeira, James P Di Santo, Phillippe J Sansonetti, Armelle Phalipon.   

Abstract

The T cell response to Shigella, the causative agent of bacillary dysentery, remains poorly understood. Using a murine model of infection, we report that Shigella flexneri primes predominately IL-17A- and IL-22-producing Th17 cells. Shigella-specific Th1 cells are only significantly induced on secondary infection, whereas specific Th2 and CD8(+) T cells are undetectable. Apart from Th17 cells that are primed in a MHC class II- and IL-6-dependent, but IL12/23p40-independent manner, we identified gammadelta T cells as an additional but minor source of IL-17A. Priming of IL-17A(+) gammadelta T cells is dependent on IL12/23p40, but independent of MHC-class II and IL-6. Th17 cells have emerged as important players in inflammatory, autoimmune, and infectious diseases. Among the yet unresolved questions is their role in long-term immunity to pathogens. In this study, we show that the elicited S. flexneri-specific Th17 pool gives rise to an enhanced recall response up to 12 mo after priming, suggesting the presence of a long-term memory state. The clearance of primary infection is impaired in the absence of T cells, but independently of IL-17A. However, after reinfection, IL-17A produced by S. flexneri-specific Th17 cells becomes important to ultimately restrict bacterial growth. These findings bring new insights into the adaptive immune response to Shigella infection and highlight the importance of pathogen-specific Th17 cell immunity for secondary immune protection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089698     DOI: 10.4049/jimmunol.0900978

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Authors:  Xiaotong Chen; Shyamal P Choudhari; Francisco J Martinez-Becerra; Jae Hyun Kim; Nicholas E Dickenson; Ronald T Toth; Sangeeta B Joshi; Jamie C Greenwood; John D Clements; William D Picking; C Russell Middaugh; Wendy L Picking
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

Review 2.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

3.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

4.  Interindividual variability and co-regulation of DNA methylation differ among blood cell populations.

Authors:  Monique Jacoby; Sandra Gohrbandt; Victor Clausse; Nicolaas H Brons; Claude P Muller
Journal:  Epigenetics       Date:  2012-11-14       Impact factor: 4.528

5.  Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.

Authors:  Thomas Lindenstrøm; Joshua Woodworth; Jes Dietrich; Claus Aagaard; Peter Andersen; Else Marie Agger
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

Review 6.  Vaccine approaches for multidrug resistant Gram negative infections.

Authors:  Brian Campfield; Kong Chen; Jay K Kolls
Journal:  Curr Opin Immunol       Date:  2014-03-15       Impact factor: 7.486

7.  E2~Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis.

Authors:  Jonathan N Pruneda; F Donelson Smith; Angela Daurie; Danielle L Swaney; Judit Villén; John D Scott; Andrew W Stadnyk; Isolde Le Trong; Ronald E Stenkamp; Rachel E Klevit; John R Rohde; Peter S Brzovic
Journal:  EMBO J       Date:  2014-01-20       Impact factor: 11.598

Review 8.  Mucosal immunity to pathogenic intestinal bacteria.

Authors:  Araceli Perez-Lopez; Judith Behnsen; Sean-Paul Nuccio; Manuela Raffatellu
Journal:  Nat Rev Immunol       Date:  2016-02-22       Impact factor: 53.106

Review 9.  Immunomodulation for gastrointestinal infections.

Authors:  Roberto J Cieza; Anthony T Cao; Yingzi Cong; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

10.  25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease.

Authors:  Lars E Bartels; Søren P Jørgensen; Mia Bendix; Christian L Hvas; Jørgen Agnholt; Ralf Agger; Jens F Dahlerup
Journal:  Inflammopharmacology       Date:  2013-01-23       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.